A triple advantage can be achieved by shifting Mexicans' current diet toward that of the recommended Healthy and Sustainable ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Hypnosis may be a feasible and cost-effective intervention for managing wound-related pain during the removal of skin ulcers ...